Pin1 allows for differential Tau dephosphorylation in neuronal cells

Molecular and Cellular Neuroscience

Volumn 32, Issue 1-2, 2006, Pages 155-160

  Hamdane, Malika ^a,b   Dourlen, Pierre ^a,b   Bretteville, Alexis ^a,b   Sambo, Anne Véronique ^a,b   Ferreira, Stéphanie ^a,b   Ando, Kunie ^a,b   Kerdraon, Olivier ^a,b   Bégard, Séverine ^a,b   Geay, Linda ^a,b   Lippens, Guy ^c   Sergeant, Nicolas ^a,b   Delacourte, André ^a,b   Maurage, Claude Alain ^a,b   Galas, Marie Christine ^a,b   Buée, Luc ^a,b  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Alzheimer's disease; Neuronal differentiation; Peptidyl prolyl cis trans isomerase; Tau phosphorylation

Indexed keywords

CIS TRANS ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHOPROTEIN; TAU PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

EID: 33745095542     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2006.03.006     Document Type: Article

References (37)

1. Augustinack J.C., Schneider A., Mandelkow E.M., and Hyman B.T. Specific Tau phosphorylation sites correlates with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103 (2002) 26-35
2. Buée L., Bussière T., Buée-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33 (2000) 95-130
3. Buée-Scherrer V., Condamines E., Mourton-Gilles C., Jakes R., Goedert M., Pau B., and Delacourte A. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol. Brain Res. 39 (1996) 79-88
4. Cruz J.C., Tseng A.C., Goldman J.A., Shih H., and Tsai L.H. Aberrant cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40 (2003) 471-483
5. Delobel P., Flament S., Hamdane M., Mailliot C., Sambo A.V., Begard S., Sergeant N., Delacourte A., Vilain J.P., and Buee L. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J. Neurochem. 83 (2002) 412-420
6. Ferreira S., Dupire M.J., Delacourte A., Najib J., and Caillet-Boudin M.L. Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons. Exp. Neurol. 166 (2000) 415-421
7. Hamdane M., Smet C., Sambo A.V., Leroy A., Wieruszeski J.M., Delobel P., Maurage C.A., Ghestem A., Wintjens R., Bégard S., Sergeant N., Delacourte A., Horvath D., Landrieu I., Lippens G., and Buée L. Pin 1 a therapeutic target in Alzheimer neurodegeneration. J. Mol. Neurosci. 19 (2002) 275-287
8. Hamdane M., Sambo A.V., Delobel P., Bégard S., Violleau A., Delacourte A., Bertrand P., Benavides J., and Buée L. Mitotic-like Tau phosphorylation by p25-Cdk5 kinase complex. J. Biol. Chem. 278 (2003) 34026-34034
9. Hamdane M., Bretteville A., Sambo A.V., Schindowski K., Bégard S., Delacourte A., Bertrand P., and Buée L. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J. Cell Sci. 118 (2005) 1291-1298
10. Haque N., Tanaka T., Iqbal K., and Grundke-Iqbal I. Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells. Brain Res. 838 (1999) 69-77
11. Holzer M., Gartner U., Stobe A., Hartig W., Gruschka H., Bruckner M.K., and Arendt T. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol. (Berl) 104 (2002) 471-481
12. Liou Y.C., Sun A., Ryo A., Zhou X.Z., Yu Z.X., Huang H.K., Bronson R., Bing G., Li X., Hunter T., and Lu K.P. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424 (2003) 556-561
13. Lu K.P. Pinning down cell signalling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29 (2004) 200-209
14. Lu K.P., Hanes S.D., and Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380 (1996) 544-547
15. Lu P.J., Wulf G., Zhou X.Z., Davies P., and Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399 (1999) 784-788
16. Lu P.J., Zhou X.Z., Liou Y.C., Noel J.P., and Lu K.P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 277 (2002) 2381-2384
17. Lu K.P., Liou Y.C., and Vincent I. Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer's disease. BioEssays 25 (2003) 174-181
18. Mailliot C., Bussière T., Hamdane M., Sergeant N., Caillet-Boudin M.L., Delacourte A., and Buée L. Pathological tau phenotypes: the weight of mutations, polymorphisms and differential neuronal vulnerabilities. Ann. N. Y. Acad. Sci. 920 (2000) 107-114
19. Noble W., Olm V., Takata K., Casey E., Mary O., Meyerson J., Gaynor K., LaFrancois J., Wang L., Kondo T., Davies P., Burns M., Nixon R., Dickson D., Matsuoka Y., Ahlijanian M., Lau L.F., and Duff K. Cdk5 is a key factor in tau aggregation and tangles formation in vivo. Neuron 38 (2003) 555-565
20. Quandt K., Frech K., Karas H., Wingender E., and Werner T. MatInd and MatInspector-New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23 (1995) 4878-4884
21. Ramakrishnan P., Dickson D.W., and Davies P. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol. Dis. 14 (2003) 251-264
22. Rippmann J.F., Hobbie S., Daiber C., Guilliard B., Bauer M., Birk J., Nar H., Garin-Chesa P., Rettig W.J., and Schnapp A. Phosphorylation dependent proline isomerisation catalysed by Pin 1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ. 11 (2000) 409-416
23. Segat L., Pontillo A., Annoni G., Trabattoni D., Vergani C., Clerici M., Arosio B., and Crovella S. Pin1 promoter polymorphisms are associated with Alzheimer's disease. Neurobiol. Aging (2005) (Dec 27, electronic publication ahead of print)
24. Sengupta A., Kabat J., Novak M., Wu Q., Grundke-Iqbal I., and Iqbal K. Phosphorylation of Tau at both Thr231 and Ser262 is required for maximal inhibition of its binding to microtubules. Arch. Biochem. Biophys. 357 (1998) 299-309
25. Shen M., Stukenberg P.T., Kirschner M.W., and Lu K.P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev. 12 (1998) 706-720
26. Smith C.J., Anderton B.H., Davis D.R., and Gallo J.M. Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells. FEBS Lett. 375 (1995) 243-248
27. Sultana R., Poon H.F., Cai J., Pierce W.M., Merchant M., Klein J.B., Markesbery W.R., and Butterfield D.A. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol. Dis. 22 (2006) 76-87
28. Thorpe J.R., Rulten S.L., and Kay J.E. The binding of a putative and a known chaperone protein revealed by immunogold labelling transmission electron microscopy: a suggested use of chaperones as probes for the distribution of their target proteins. J. Histochem. Cytochem. 47 (1999) 1633-1640
29. Thorpe J.R., Morley S.J., and Rulten S.L. Utilising the peptidyl prolyl cis-trans isomerase Pin 1 as a probe of its phosphorylated target proteins: examples of binding to nuclear proteins in a human kidney cell line and to Tau in Alzheimer's diseased brain. J. Histochem. Cytochem. 49 (2001) 97-108
30. Thorpe J.R., Mosaheb S., Hashemzadeh-Bonehi L., Cairns N.J., Kay J.E., Morley S.J., and Rulten S.L. Shortfalls in the peptidyl prolyl cis-trans isomerase protein Pin 1 in neurons are associated with frontotemporal dementias. Neurobiol. Dis. 17 (2004) 237-249
31. Vincent I., Rosado M., and Davies P. Mitotic mechanisms in Alzheimer's disease?. J. Cell. Biol. 132 (1996) 413-425
32. Vincent I., Zheng J.H., Dickson D.W., Kress Y., and Davies P. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging 19 (1998) 287-296
33. Wintjens R., Wieruszeski J.M., Drobecq H., Rousselot-Pailley P., Buée L., Lippens G., and Landrieu I. 1H NMR study on the binding of Pin1 WW domain with phosphothreonine peptides. J. Biol. Chem. 276 (2001) 25150-25156
34. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., and Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20 (2001) 3459-3472
35. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., Cantley L.C., and Lu K.P. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278 (1997) 1957-1960
36. Zhang J., Moseley A., Jegga A.G., Gupta A., Witte D.P., Sartor M., Medvedovic M., Williams S.S., Ley-Ebert C., Coolen L.M., Egnaczyk G., Genter M.B., Lehman M., Lingrel J., Maggio J., Parysek L., Walsh R., Xu M., and Aronow B.J. Neural system-enriched gene expression: relationship to biological pathways and neurological diseases. Physiol. Genomics 18 (2004) 167-183
37. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., Kullertz G., Stark M., Fischer G., and Lu K.P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6 (2000) 873-883